Researchers continue to excited about this new drug, a innovative dual compound showing promising data in early trials for weight management. It acts by modulating two pathways : GLP-1 and GIP, these, when stimulated, support regulate cravings and enhance energy expenditure . Early findings demonstrate considerable body reduction and possible impro